首页> 外文期刊>Biomedical Research >Interaction of histamine and calcitonin gene-related peptide in the formalin-induced pain perception in rats
【24h】

Interaction of histamine and calcitonin gene-related peptide in the formalin-induced pain perception in rats

机译:组胺和降钙素基因相关肽在福尔马林引起的大鼠痛觉中的相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

Histamine and calcitonin gene-related peptide (CGRP) contribute to the pain perception. The aim of the present study is to clarify the interaction of histamine and CGRP in the perception of inflammatory pain. The effects of a histamine H1 receptor antagonist (pyrilamine, i.p.), an H2 receptor antagonist (ranitidine, i.p.) and a CGRP antagonist (CGRP 8-37, i.t.) on the formalin-induced pain was studied in rats. Pyrilamine and ranitidine produced a dose-dependent antinociceptive response in the first and the second phases of the formalin test. A single administration of pyrilamine (1 mg/kg, i.p.), ranitidine (10 mg/kg, i.p.) or CGRP 8-37 (10 μg/μL, i.t.) had no significant effects on the pain perception in the second phase. A combination of CGRP 8-37 and pyrilamine or ranitidine at these sub-effective doses, however, showed nociceptive response in the second phase. Moreover, a histamine (i.t.)-induced hyperalgesia was completely prevented by treatment with GGRP 8-37 at this dose. Our findings have raised the possibility that the CGRP system has interaction with histamine in the perception of inflammatory pain.
机译:组胺和降钙素基因相关肽(CGRP)有助于疼痛感。本研究的目的是阐明组胺和CGRP在炎症性疼痛的感知中的相互作用。在大鼠中研究了组胺H1受体拮抗剂(吡咯胺,i.p。),H2受体拮抗剂(ranitidine,i.p.)和CGRP拮抗剂(CGRP 8-37,i.t.)对福尔马林诱导的疼痛的影响。吡咯胺和雷尼替丁在福尔马林测试的第一阶段和第二阶段产生剂量依赖性的抗伤害感受性反应。吡咯胺(1 mg / kg,腹腔内),雷尼替丁(10 mg / kg,腹腔内)或CGRP 8-37(10μg/μL,腹腔内)的单次给药对第二阶段的疼痛知觉没有显着影响。这些次有效剂量的CGRP 8-37和吡咯胺或雷尼替丁的组合在第二阶段显示出伤害性反应。此外,通过以该剂量的GGRP 8-37治疗,完全防止了组胺(i.t.)诱导的痛觉过敏。我们的发现提高了CGRP系统与组胺在炎症性疼痛方面的相互作用的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号